Editorial
doi: 10.1056/NEJMe2101705.
Epub 2021 Feb 10.
STEP 1 for Effective Weight Control - Another First Step?
Affiliations
- PMID: 33567184
- DOI: 10.1056/NEJMe2101705
Item in Clipboard
Editorial
STEP 1 for Effective Weight Control - Another First Step?
N Engl J Med.
.
Erratum in
-
STEP 1 for Effective Weight Control - Another First Step?N Engl J Med. 2021 Jun 24;384(25):2454. doi: 10.1056/NEJMx210007. N Engl J Med. 2021. PMID: 34161721 No abstract available.
No abstract available
Comment on
-
Once-Weekly Semaglutide in Adults with Overweight or Obesity.N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. N Engl J Med. 2021. PMID: 33567185 Clinical Trial.
Similar articles
-
The STEP 1 trial for weight loss: a step change in treating obesity?Nat Med. 2021 Apr;27(4):589-590. doi: 10.1038/s41591-021-01319-4. Nat Med. 2021. PMID: 33859431 No abstract available.
-
In adults with overweight or obesity, continued weekly semaglutide after a 20-wk run-in improved weight loss.Ann Intern Med. 2021 Aug;174(8):JC88. doi: 10.7326/ACPJ202108170-088. Epub 2021 Aug 3. Ann Intern Med. 2021. PMID: 34339232
-
Clinical review of subcutaneous semaglutide for obesity.J Clin Pharm Ther. 2022 Feb;47(2):184-193. doi: 10.1111/jcpt.13574. Epub 2021 Dec 28. J Clin Pharm Ther. 2022. PMID: 34964141 Review.
-
Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity.JAMA. 2021 Sep 28;326(12):1213-1214. doi: 10.1001/jama.2021.13021. JAMA. 2021. PMID: 34581745 No abstract available.
-
Antidiabetikum vor neuer Karriere.MMW Fortschr Med. 2021 May;163(9):26. doi: 10.1007/s15006-021-9940-5. MMW Fortschr Med. 2021. PMID: 33961244 Review. German. No abstract available.
Cited by
-
Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential.Toxicol Rep. 2025 Jan 16;14:101895. doi: 10.1016/j.toxrep.2025.101895. eCollection 2025 Jun. Toxicol Rep. 2025. PMID: 39911322 Free PMC article. Review.
-
Research in brief: Effective pharmacotherapy for the management of obesity.Clin Med (Lond). 2021 Sep;21(5):e517-e518. doi: 10.7861/clinmed.2021-0253. Epub 2021 Aug 11. Clin Med (Lond). 2021. PMID: 34385300 Free PMC article. No abstract available.
-
Genomics and phenomics of body mass index reveals a complex disease network.Nat Commun. 2022 Dec 29;13(1):7973. doi: 10.1038/s41467-022-35553-2. Nat Commun. 2022. PMID: 36581621 Free PMC article.
-
Cardiovascular Safety and Superiority of Anti-Obesity Medications.Diabetes Metab Syndr Obes. 2021 Jul 13;14:3199-3208. doi: 10.2147/DMSO.S311359. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34285527 Free PMC article. Review.
-
Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo.Mol Metab. 2021 Dec;54:101352. doi: 10.1016/j.molmet.2021.101352. Epub 2021 Oct 6. Mol Metab. 2021. PMID: 34626854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
